Indeed, Sjögren’s syndrome patients demonstrate marked decreases in their serum DHEA and androgen levels and reduced androgen receptor activity, as revealed by the decreased expression of CRISP-3 [38, 39]. This evidence concerns the gene CRISP3 and Sjogren syndrome.